Annalyn Frame

Translational Medicine Alliance Announces 2010 Forum

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Ewing Marion Kauffman Foundation

A Biomedical Industry Collaboration for Innovation

KANSAS CITY, MO–(Marketwire – July 21, 2010) – The Translational Medicine Alliance Forum will convene October 13-14, 2010 at the Mandarin Oriental in Washington, DC. This year’s Forum will be hosted by three organizations with the common interest of accelerating translational research to the patient.

The Forum brings together leaders from academia, government agencies, and pharmaceutical, biotechnology and venture industries to work toward developing a deeper understanding of effective models to enable and accelerate the progress of translational medicine. Through focused, dynamic sessions and exclusive networking opportunities, attendees have the opportunity to learn about breakthrough approaches and progress on current best practices in translational medicine collaborations.

“Translational medicine holds some of the most promising advancements, and through this Forum, we are able to help facilitate and encourage a steady pathway to success for current and future research,” said Lesa Mitchell, vice president of Advancing Innovation, Ewing Marion Kauffman Foundation. The Kauffman Foundation helped found the Translational Medicine Alliance in 2007.

This Forum will focus on the following topics: regulatory science, lessons from the most experienced translational models, how and why rare disease and pediatric medicine are changing the landscape, transparency and access to data and reverse engineering translational science starting with the patient.

The 2010 Forum is cosponsored by the Ewing Marion Kauffman Foundation, FasterCures and the Council for American Innovation. Registration for the Forum is now open. Early bird rates are available now through August 16, 2010, with a rate of $595 for corporate and $200 for academic and not-for-profit registrations. Space is limited. To register for the Forum, visit https://www.regonline.com/2010_translational_medicine_alliance_forum or call 866-831-3243.

Translational Medicine Alliance

The TransMed Partnership was formed in March 2007 to tap into the best ideas of thought leaders and develop an integrated strategy to support and advance the most promising technologies. The Alliance was founded by the Kauffman Foundation, Pfizer, Johnson and Johnson, Biogen Idec, FasterCures, Washington University, St. Louis (WUSTL) School of Medicine, BioVentures for Global Health, the Center for Emerging Technologies, BIOCOM, BIOTECanada, and LifeTech Innovations. For more information about the Alliance, please visit www.translationalmedicinealliance.org.

Contact
Jessica Cini
Translational Medicine Alliance
866-831-3243
[email protected]

VHA Study on Social Practices Reveals Manufacturers Can Help Lead Quality and Safety Efforts

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Medline Industries, Inc.

Observational Study of Clinicians Revealed Opportunities to Redesign Products to Better Support Clinician-Patient Interaction

MUNDELEIN, IL–(Marketwire – July 21, 2010) – A new VHA case study whitepaper released by Medline Industries, Inc. details how the company used observational studies and context-based design to build human factors and social behaviors into its redesigned Foley Catheter Management tray.

The whitepaper, Social Practice and Clinicians’ Meaning of Urinary Catheter Insertions, showed that the redesigned tray significantly influenced the clinician’s ability to provide high quality care by creating a greater focus on providing patient comfort, maintaining sterile technique and decreasing the time of the entire insertion process. The observational study was comprised of three separate three-day observations of clinicians conducting catheterizations in the emergency department, medical/surgical floors and operating rooms at Providence Sacred Heart Medical Center and Children’s Hospital, Spokane, WA.

“Health care manufacturers are often overlooked when clinicians redesign clinical practices. Yet, the design of a product can be key to helping clinicians improve clinical performance and patient education,” said Trent Haywood, MD, JD, Senior Vice President of Clinical Performance and Chief Medical Officer for VHA and lead investigator. “For example, Medline chose to redesign the urinary catheter tray based upon the observational data uncovered in the clinical setting. Such design emphasis shows how manufacturers can be a key partner in quality and safety.”

The unique partnership between Medline and the VHA research team highlights how industry vendors can partner with healthcare providers to develop a comprehensive system that incorporates proper procedures and social behaviors that are easy to adopt in every day practice.

Medline launched its ERASE CAUTI program, which is based on the same criteria the CDC used in developing their new CAUTI prevention guidelines, last fall. Soon after the tray’s introduction, Medline met with the VHA Clinical Performance team to discuss studying the tray and how it’s used in actual clinical practice. Emphasis was put on understanding the objectives of catheter insertions from the clinician’s perspective, clarifying the actual practice that unfolds and identifying areas where the catheter management system aided the clinician or failed to aid the clinician based upon the clinician’s perspective on the practice.

Findings summarized in a case study whitepaper showed that clinicians preferred the benefits of the single layer tray which did not require steps related to maneuvering and positioning with a two layer tray. They also preferred the change to swab sticks that decreased the number of steps in the prepping and cleansing of the perineum. Clinicians retained the patent-pending patient education card for the patient or placed it in location where the patient might review it — a departure from previously observed behavior where the education was discarded without much attention. Clinicians also used the full-colored photography packaging to better explain the procedure to patients.

“Chief Nursing Officers (CNOs) want to help their staff reduce variability in the procedures that are done so that the potential to make an error decreases,” said Connie Yuska, Medline’s Vice President of Clinical Services and a former CNO. “We redesigned the tray taking into account the interaction between the patient and the clinician and facilitate learning — things that challenge nursing leaders every day.”

The VHA whitepaper, as well as additional information on the ERASE CAUTI program, is available for download on Medline’s website at www.medline.com/erase.

About Medline Industries, Inc.
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Media Contacts:
Jerreau Beaudoin
(847) 643-3011
John Marks
(847) 643-3309

AROK Purchasing Coalition Anticipates $25 Million Savings Through New Prime Vendor Supply Agreement With Medline Industries, Inc.

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Medline Industries, Inc.

Medline Brand Products and Reduced Distribution Fees Drive Cost Savings

MUNDELEIN, IL–(Marketwire – July 21, 2010) – Medline Industries Inc., the nation’s largest privately held manufacturer and distributor of healthcare supplies, announced today the signing of a cost management prime vendor agreement with the AROK Purchasing Coalition, a VHA supply network comprised of nearly 50 acute care facilities in Arkansas and Oklahoma. The five-year agreement is anticipated to save AROK an estimated $20-$25 million over the term of the contract.

Medline is expected to generate more than $500 million in medical and surgical product sales from the partnership over the term of the agreement.

AROK was formed to help VHA member hospitals in Arkansas and Oklahoma increase efficiencies and reduce expenses by aggregating supply and services expenditures.

As part of the agreement, Medline will provide its broad array of Medline brand medical and surgical products, including surgical procedure trays, patient care products, disposable protective gowns, exam gloves and bandages. Medline will drive cost savings to AROK members by delivering products direct to the healthcare facilities from two of Medline’s distribution centers located in Oklahoma City and Memphis, Tenn.

Medline will also deliver cost savings by reducing distribution fees on other national brand products and product standardization. In addition, Medline will provide enhanced reporting capabilities and offer comprehensive product utilization, education and practical solutions to help the facility control costs and improve patient care.

About AROK
The AROK Purchasing Coalition is a VHA Supply Network. Twenty-one VHA health care organizations, representing nearly 50 hospitals in Arkansas and Oklahoma officially joined together in June 2008 to increase efficiencies and reduce expenses by aggregating supply and services expenditures. Combined annual supply purchases of the purchasing coalition represent in excess of $600 million. As a limited liability corporation, the AROK Purchasing Coalition is recognized as a single VHA member entity and as a large integrated delivery system by the supplier and distributor community. VHA operates the purchasing coalition at the direction of the members.

Medline has a growing network of 32 distribution centers around the country, as well as an expanding, dedicated transportation fleet with over 200 vehicles in a variety of sizes to fit customers’ specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication.

About VHA
VHA Inc., based in Irving, Texas, is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. Formed in 1977, through its 16 regional offices, VHA serves more than 1,400 hospitals and more than 25,500+ non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

Media Contacts:
John Marks
(847) 643-3309
Jerreau Beaudoin
(847) 643-3011

www.healthoptionsworldwide.com: Medical Tourism Trends

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Health Options Worldwide (HOW)

Employers Are Jumping on the Domestic Medical Travel Bandwagon

PRINCETON, NJ–(Marketwire – July 21, 2010) – In a recent USA Today article, medical tourism is getting a huge boost from American based employers and insurers who encourage employees to consider domestic medical travel. Therefore, instead of seeking out medical travel or affordable healthcare alternatives overseas such as Thailand or India, employees are being directed to regional facilities that offer high-quality care and lower prices. “The move is reducing healthcare costs by 20% to 40%, with the difference often covering travel expenses,” says David Goldstein, President of Health Options Worldwide (HOW), an online medical tourism company.

“When people hear the words ‘medical tourism,’ they automatically think overseas,” explained Goldstein, “But low-cost healthcare can be found in this country, even if it involves some travel.” Employers who offer domestic medical travel programs can save healthcare money by negotiating a single rate. This rate can include surgical and anesthesia fees and all medical care performed up until discharge.

Large corporations like Lowe’s, the home improvement retailer, already have such programs in place. A self-insured employer, Lowe’s struck a deal with a cardio care clinic where they send their employees for open-heart surgeries, valve repairs and pacemakers. In the future, they may add orthopedic surgeries to their program. Other large employers may soon follow suit with similar agreements with healthcare providers. Some companies provide financial incentives to medical travelers like waived deductions, copayment reductions and paid travel expenses.

“If this concept catches on, especially with large employers, it could help decrease healthcare costs and improve the quality of medical care by creating a competitive marketplace,” says Goldstein. Hospitals dictate costs and affect health insurance premiums. “However, it’s very sobering to see how much medical costs and quality can vary between hospitals and regions,” said Goldstein.

However, the focus should still be on quality along with financial balance, advises Goldstein. “With tempting financial incentives, employees may be forced to choose cost instead of quality, and the choice will be taken out of their hands,” explained Goldstein. Still the savings are hard to beat, especially when there are fewer complications from procedures that are done with high quality providers. Follow-up care, like physical therapy, is done locally and covered under the employee’s regular insurance plan.

Programs like these could spur the domestic healthcare marketplace to respond with even lower costs in order to lure patients to their centers. Insurance companies are hesitant to offer domestic medical travel incentives because it creates ill will with local healthcare providers, who then lower their costs in response. “This is why employers, healthcare providers and insurance companies will have no choice but to embrace this trend,” said Goldstein.

Contact:

David Goldstein
President
Health Options Worldwide
Domestic and International Healthcare Marketplace
Ph: 877-234-1345
www.healthoptionsworldwide.com

Click here to see all recent news from this company

Seegene Introduces First Real-time Molecular Diagnostic Test for Tuberculosis and Multi-drug Resistant Tuberculosis

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Seegene

Anyplex^TM MDR-TB Screening Test Identifies TB and Genetic Mutations Leading to TB Resistance to Isoniazid and Rifampicin

ROCKVILLE, MD and SEOUL, KOREA–(Marketwire – July 21, 2010) – The emergence and spread of drug-resistant mycobacterium tuberculosis (TB) threatens global TB control efforts, and there is an urgent need for new diagnostic tests that rapidly identify drug sensitivity profiles of TB strains. To help address these concerns, Seegene today introduced Anyplex™ MDR-TB Screening Test, the first real-time PCR molecular diagnostic capable of simultaneous detection of TB and genetic mutations leading to multi-drug resistant TB (MDR-TB) within four hours.

Seegene Anyplex™ MDR-TB Test will be introduced at the 2010 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), booth #1800.

According to the World Health Organization (WHO), TB strains that are resistant to all major anti-TB drugs have been documented in every country by the non-governmental organization recent survey. A particularly dangerous form of drug-resistant TB is multi-drug resistant TB (MDR-TB), which is defined as the disease caused by TB bacilli resistant to, among others, the two most powerful anti-TB drugs, isoniazid (INH) and rifampicin (Rif).The rate for successful MDR-TB treatment is extremely low and the progress of the disease is faster than normal TB, resulting in 40-50% of mortality rate. Rates of MDR-TB are troublingly high in some countries, especially in the former Soviet Union, and threaten TB infectious disease control efforts. WHO estimates that more than 440,000 people are infected with MDR-TB.

Using Anyplex^™ MDR-TB Screening Test, healthcare workers will be able to quickly determine whether or not a patient is infected with a strain of TB that is resistant to INH and Rif. The Anyplex^™ MDR-TB is a real-time detection test of M. tuberculosis that quickly and comprehensively determines the levels of targets in a patient’s various sample types, and identifies mutations of drug resistant genes to better inform a diagnosis.

Because genetic mutations that lead to antibiotic resistance are minute and sit close together, so far conventional PCR or conventional real-time PCR tests are not able to discriminate these mutations accurately within the same test procedure. In contrast, the Anyplex MDR-TB test can detect the mutations of drug resistant genes to Rif (rpoB: D516V/Y, H526D/Y, S531L) and INH (katG: S315T (2 cases); inhA promoter: -15(C/T)). The unprecedented speed and accuracy of the Anyplex MDR-TB Tests will enable doctors and clinicians to quickly provide an appropriate treatment to prevent the spread of MDR-TB.

Seegene’s new MDR-TB test takes TB diagnostics to a new level. Current TB test methods are hindered by speed (culture typically required 2-8 weeks for results), low sensitivity (acid-fast bacilli smear microscopy produced results in 24 hours but at the cost of missing a significant portion of TB cases) and low specificity (culture and microscopy methods not being able to efficiently differentiate between M. tuberculosis and non-tuberculosis mycobacteria). Furthermore, none of these approaches are able to rapidly and efficiently identify a patient’s resistance to the major drugs for treating TB — INH and Rif. Even if sequencing and Line Probe Assay are available to test drug resistance, the procedures are quite complicated and time-consuming.

“Making a fast and accurate diagnosis of the type of TB infection a patient may have is the most important step to curing a patient. Because MDR-TB is difficult to treat, preventing its spread throughout the population is essential. The Anyplex^™ MDR-TB Test is a powerful new tool that healthcare workers can use to rapidly determine MDR-TB infections, which will both help stop it from spreading and allow health care professionals to set a course of alternative medications for infected patients,” said Jong-Yoon Chun, chief executive officer of Seegene.

Anyplex^™ MDR-TB Test will not be available in the USA until regulatory clearance.

About Seegene

Seegene, Inc. is the leading biotechnology company developing, manufacturing and marketing innovative molecular diagnostic products. The company’s proprietary technologies in both PCR and Real-time PCR named ACP™, DPO™, and READ™, set a new solution for high-throughput and simultaneous multi-pathogen detection called “multiplex PCR”. The novel Real-time PCR technology, READ™, overcomes the limitations of conventional Real-time PCR, providing dramatic improvement in sensitivity and specificity. Seegene holds three novel Molecular diagnostic platforms: Seeplex^® system adapting DPO™ Technology, Anyplex™ and Magicplex™ systems that are Real-time PCR detection platforms adapting DPO™ and READ™ technologies. Seegene’s products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology using the innovative proprietary technologies.

For more information please visit www.seegene.com or call +301-762-9066.

Contacts:
Miyoun Lee, MSc
Seegene Inc.
301-762-9066
or
Constantine Theodoropulos
Base Pair Communications
617-816-4637

Medcor Recognized by Staples for Injury Triage Service

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Medcor, Inc

MCHENRY, IL–(Marketwire – July 21, 2010) – Medcor, Inc. announced its receipt of Staples’ Supplier of the Year award for Loss Prevention, recognizing Medcor’s contribution to improving health outcomes and controlling health costs. Medcor provides a 24/7 telephonic injury triage service for all Staples retail stores in North America. The service gives Staples employees immediate access to a registered nurse via a toll-free line to help determine the best course of action in the event of injury or illness at work. The service directs employees in first aid and self care, and makes referrals to appropriate off-site care for further treatment and diagnosis when necessary. More than 100 other vendors were considered in the selection process for this award. The award was presented to Medcor by Staples executives Wayne Jacobson and Dan Provost. Staples is the world’s largest office products company.

“This is an important honor from an important client,” said Medcor President and CEO Philip Seeger, as he shared the award with nurses in Medcor’s call center in McHenry, Illinois. “Our nurses combine their experience and training with our software and clinical algorithms to deliver a very effective clinical intervention. The whole system is designed to work seamlessly within our client’s safety and risk management program.”

Medcor’s triage process is covered by three US patents, with additional patents pending. Medcor’s triage service is currently used by over 70,000 work locations from a variety of industries, including many national retailers.

About Medcor

Medcor helps employers reduce costs of workers’ compensation and general health care. Medcor services include telephonic injury triage, on-site health and wellness clinics, outsourced safety staff, and employee screening. Medcor’s services are available 24/7 nationwide for worksites of any size in many industries. Headquartered in McHenry, IL, the company provides triage services to nearly 70,000 worksites in all 50 states and operates 163 on-site workplace clinics. Medcor’s triage methods are covered by U.S. & foreign patents, including U.S. No. 7,668,733; 7,716,070; & 7,720,692; other patents pending.

For more information, please contact: Kate Woldhuis at [email protected]

Contact:
Kate Woldhuis
[email protected]

Datalliance VMI Customer, Bracco Diagnostics, Reviewed in Analyst Case Study on Healthcare Supply Chain

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Datalliance

Datalliance Identified as Vendor Managed Inventory Platform and Partner for Program

CINCINNATI, OH–(Marketwire – July 21, 2010) – The Vendor Managed Inventory (VMI) strategy being developed by Bracco Diagnostics, a leading provider of contrast media and related equipment to hospitals and imaging centers, was recently featured in a Gartner report on supply chain innovations in the healthcare industry titled “Case Study: Bracco Diagnostics Leverages Datalliance for Downstream Customer Alliances” published July 8, 2010.

The case study discusses Bracco Diagnostics’ success with the first phase of their VMI program within its own distribution network, as well as the company’s strategy to offer VMI to key customers as a value-added service to manage inventory, prevent stock-outs, and optimize procure-to-pay processes.

Addressing the challenges to collaborative supply chain processes such as VMI in the healthcare industry, the report lists the following as lessons learned:

“Trading partners must be willing to collaborate on the development of improved business processes, increasing the level of trust by establishing bidirectional goals and measures.
Both the hospital and upstream supplier must start by thinking from the patient back. They should then develop innovative solutions to age-old challenges, such as inefficient transactions, bloated network inventories and less-than-optimal customer satisfaction.
There are a host of ancillary benefits to establishing robust VMI capabilities between trading partners. For example, the cycle time required to renegotiate supply contracts can be greatly reduced when both parties have a clear line of sight to expected volumes, supplier performance and customer satisfaction.”

The full report is available to Gartner clients at www.gartner.com/resId=1397037.

“VMI continues to expand in the healthcare industry and we’re proud to be working with forward-thinking suppliers like Bracco Diagnostics and others to leverage it as one means of bringing down the cost of patient care,” said Bob Jennings, Datalliance VP of Sales & Marketing. “This is another example of the many successful VMI programs within our customer community.”

Earlier, Datalliance VMI was positively referenced in the AMR Research report titled “The Resurgence of Vendor Managed Inventory: A Landscape” published in October 2009. Visit www.datalliance.com/2009_dec_pr1.html for more information about that report, which is also available on the Gartner web site for companies with appropriate subscriptions. AMR Research is now part of Gartner.

About Datalliance
Datalliance is a leading provider of collaborative commerce services, and the world’s largest independent VMI service provider. Delivered via the Internet using the ‘Software as a Service’ (SaaS) model, Datalliance solutions make it easy for suppliers and their customers to establish sales and inventory management relationships that fully align business objectives, improve collaboration, and streamline supply chain operations. Datalliance manages billions of dollars in orders, millions of SKUs, and thousands of locations for leading Fortune 1000 companies in a number of industries. For more information about Datalliance, visit www.datalliance.com

Contact:
Brian Lindner
Datalliance
513-791-7272

Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Radient Pharmaceuticals Corporation

Newest Commercialization Milestone Brings RPC’s Onko-Sure^TM IVD Cancer Test to Australia and New Zealand Markets

TUSTIN, CA–(Marketwire – July 21, 2010) – Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based pharmaceutical company specializing in the research, development and sales of In Vitro Diagnostic (IVD) cancer tests, announced today it has entered into an exclusive distribution agreement with AMDL Australia Pty Ltd. to market and commercialize RPC’s Onko-Sure™ in vitro diagnostic (IVD) cancer test in Australia and New Zealand.

Led by a strong management team of well-respected physicians and diagnostics professionals, AMDL Australia Pty Ltd. is an established, privately?owned distributor of healthcare products to laboratories, clinics, hospitals and other health care providers and research organizations throughout Australia and New Zealand. The company is the newest addition to Radient Pharmaceuticals’ portfolio of international distributors and under the terms of the agreement, will market, sell and distribute at minimum 3700 Onko?Sure IVD cancer test kits for use as a monitoring test for colorectal cancer (CRC) in Australia and New Zealand. AMDL Australia also holds responsibility for developing and executing a full-scale marketing strategy to drive product awareness and engage healthcare decision makers, thought?leaders, lab directors, physicians, patients and healthcare consumers in product purchases. Targeted distribution channels will include medical centers, hospitals, clinical laboratories, university labs.

According to Douglas MacLellan, Chairman and CEO of RPC, “We are extremely pleased to further expand the commercial availability of Onko-Sure through this partnership with AMDL Australia, a leading distributor in Australia and New Zealand. AMDL Australia has a well-established and significant sales force with a successful track record in these markets where we have not yet established a full commercial sales presence for Onko-Sure. Through this partnership, Onko-Sure will be available sooner and to more patients than otherwise possible in these selected markets.”

AMDL Australia’s Dr Chris Dirks remarked, “Epidemiological evidence estimates there are more than 13,000 new cases of CRC in Australia annually. CRC is a leading cause of cancer death in this country and through national cancer screening programs with the use of Onko-Sure we can enable health care providers with the ability to provide early detection, treatment and more vigilant monitoring, which in turn can lead to decreased mortality rates. We are pleased to be the exclusive distributor of Onko-Sure in the Australian and New Zealand markets.”

Onko?Sure is a simple, non?invasive, patent?pending and regulatory?approved in vitro diagnostic test that enables physicians and their patients to effectively monitor and/or detect certain types of cancers by measuring the accumulation of specific breakdown products in the blood called Fibrin and Fibrinogen Degradation Products (FDP). FDP levels rise dramatically with the progression of cancer. The test is approved for laboratory use in Australia and follows FDA clearance for the post treatment phase monitoring of patients with CRC. The test is a standard ELISA test can be requested for patients with CRC on regular pathology request forms by their physicians.

RPC Contact Information:
For additional information on Radient Pharmaceuticals, ADI and its portfolio of products visit the Company’s corporate website at www.Radient-Pharma.com. For Investor Relations information contact Kristine Szarkowitz at [email protected] or 1.206.310.5323.

About Radient Pharmaceuticals:
Headquartered in Tustin, California, Radient Pharmaceuticals is dedicated to saving lives and money for patients and global healthcare systems through the deployment of our Onko-Sure™ In Vitro Diagnostic cancer test. Our focus is on the discovery, development and commercialization of unique high-value diagnostic tests that help physicians answer important clinical questions related to early disease detection; treatment strategy; and the monitoring of disease progression, prognosis, and diagnosis to ultimately improve outcomes for patients. Radient Pharmaceutical’s current Onko-Sure™ cancer test is used to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, perform additional testing, or assist in the selection of therapy. To learn more about our company, people and potentially life-saving cancer test, visit www.radient-pharma.com.

Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

RPC Contact:
Kristine Szarkowitz
Director-Investor Relations
Email Contact
Tel: 206.310.5323

Click here to see all recent news from this company

Philips and Dako Join Forces in Digital Pathology

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Dako

EINDHOVEN, THE NETHERLANDS and GLOSTRUP, DENMARK–(Marketwire – July 21, 2010) – Royal Philips Electronics (NYSE: PHG)(AEX: PHI) and Dako, a Danish company specializing in tissue-based cancer diagnostics, today announced that they have signed an agreement to integrate a selection of Dako’s image analysis applications into Philips’ future digital pathology solutions.

“Anatomic pathology is an essential element of virtually every cancer diagnosis and the demand for it is ever-increasing. Our goal is to develop integrated digital solutions that enhance the operational efficiency and productivity of pathology departments, as well as increasing diagnostic confidence,” says Bob van Gemen, General Manager of Philips Digital Pathology. “I am convinced that our partnership with Dako, with its leading market position and expert knowledge in detecting and quantifying specific biomarkers in cancer tissue, will significantly accelerate our clinical applications development program.”

“We are very pleased to announce this collaboration with Philips, a leading company in the healthcare industry that is committed to entering the digital pathology market,” says Lars Holmkvist, CEO of Dako. “By joining forces with Philips, we will be able to deliver highly competitive diagnostic tools based on Philips’ extensive clinical expertise and technology know-how and Dako’s expertise in advanced staining and image analysis in order to benefit pathology laboratories, pathologists and ultimately patients.”

Currently, anatomic pathology workflows to examine tissue samples are based on the microscope, through which pathologists examine tissue sections mounted on glass slides and treated with different stains. The staining enhances the contrast between, or reveals the presence of, cellular and molecular components such as cell nuclei or specific proteins. Accurate interpretation of the results is critical to the diagnosis and staging of each individual patient’s disease and requires a great deal of skill and experience. Digitizing the images that pathologists normally view through a microscope may enable the introduction of objective and quantitative image analysis tools.

Dr. Clive Taylor, MD, PhD, Professor at University of Southern California, USA, and a renowned expert in pathology, expresses about the collaboration: “Digital pathology has been long in gestation, in comparison to radiology, where images also are the currency of practice, and where image acquisition, transfer, interpretation and storage is almost entirely digital. In part, this lag is because acquisition of histopathology images is dependent upon a 100 year old technique of ’tissue fixation’, sectioning and staining. In part, it is because, somewhat surprisingly, fully digitized histopathology images are much larger than CT files, and difficult to manage and analyze. Progress has been slow because there has been no single institution, or company, that embraces both of these areas. It is exciting that collaborations like that between Dako and Philips are now bringing diverse but appropriate expertise to bear on implementing a full digital pathology program.”

A fast pathology slide scanner and an associated image management system form the basis of Philips’ proposed integrated solutions for digitizing pathology workflows. The Philips-Dako collaboration will initially focus on leveraging Dako’s image analysis software for tissue-based breast cancer diagnosis using its reagents for staining HER2, Estrogen Receptor (ER), Progesterone Receptor (PR), p53 and Ki-67 proteins. The detection and quantification of these proteins in biopsy tissue are highly relevant for the classification of breast cancers and the selection of appropriate therapy. Philips and Dako will also explore the possibility of extending the collaboration to include image analysis software for immunohistology-based prostate and colon cancer diagnostics.

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG)(AEX: PHI) is a diversified health and well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs more than 116,000 employees in more than 60 countries worldwide. With sales of EUR 23 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

About Dako
Dako, based in Denmark, is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako’s know-how, reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer. Employing more than 1000 people and being present in more than 80 countries, Dako covers essentially all of the anatomic pathology markets globally. Dako is owned by a private equity fund, EQT. www.dako.com

For further information, please contact
Philips
Steve Klink
Tel.: +31 40 27 43703
Mobile: +31 6 10888824
E-mail: [email protected]

Dako
Maia Fredtoft Søchting
Tel.: +45 44859352
Mobile: +45 25461083
E-mail: [email protected]

Allied Healthcare International Inc. to Host Fiscal 2010 Third Quarter Conference Call and Webcast

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: Allied Healthcare International Inc.

NEW YORK, NY–(Marketwire – July 21, 2010) – Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI) will host a conference call and webcast to discuss the financial and operating performance for its fiscal 2010 third quarter ended June 30, 2010 on Tuesday, August 3, 2010, at 10:00 AM Eastern Time / 3:00 PM UK Time. The call will be hosted by Sandy Young, Chief Executive Officer, and Paul Weston, Chief Financial Officer. The Company will issue its earnings press release prior to the call.

Dial-In Information
Allied invites all those interested in listening to management’s discussion of the results to join the call by dialing (877) 407-8031 for domestic participants and (201) 689-8031 for international participants. Participants may also access a live webcast of the conference call through the “Investors” section of Allied Healthcare’s Website: www.alliedhealthcare.com.

A telephone replay will be available for one week following the call by dialing (877) 660-6853 for domestic participants and (201) 612-7415 for international participants. When prompted, please enter account number 286 and conference ID number 353906. A webcast replay will also be available and archived on the Company’s website for ninety days.

ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.
Allied Healthcare International Inc. is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of over 110 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of private patients, community care, nursing and care homes, and hospitals. For more news and information please visit: www.alliedhealthcare.com.

CONTACT
Allied Healthcare International Inc.
Sandy Young
Chief Executive Officer
Paul Weston
Chief Financial Officer
+44 1785 810600

Piper Jaffray Ltd. (Nominated Advisor)
Matthew Flower
Rupert Winckler
+44 20 3142 8700

ICR Inc.
Sherry Bertner
Managing Director
+1 646 277 1200
[email protected]

Breakthrough Publication (July 2010): FONAR UPRIGHT MRI Detects Injuries in Symptomatic Motor Vehicle Whiplash Patients Missed by Conventional…

Posted on July 21, 2010 Written by Annalyn Frame

SOURCE: FONAR Corporation

MELVILLE, NY–(Marketwire – July 21, 2010) – FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™ announces new breakthrough results for the FONAR UPRIGHT® Multi-Position™ MRI. The medical journal “Brain Injury” (July 2010:24(7-8):988-994) has just released the exciting results of a study of 1200 neck pain patients. The study was published by 10 authors from distinguished universities in the U.S. and around the world (University of Oregon, University of Aarhus, Denmark, University of Aberdeen, Scotland, Columbia University, Portland State University) of their results from the scans of 1200 patients. Their study reported that 150% more whiplash patients (Table II – % CTE Trauma Patients) had demonstrable radiographic pathology when scanned upright than when they were scanned lying down (recumbent). Their investigation also reported that “patients with a history of motor vehicle crash-associated neck pain have a substantially higher frequency of cerebellar tonsillar ectopia (CTE)* of 1mm or more than non-traumatic subjects” when examined by the FONAR UPRIGHT® MRI. The authors were Michael D. Freeman, Scott Rosa, David Harshfield, Francis Smith, Robert Bennett, Christopher J. Centeno, Ezriel Kornel, Ake Nystrom, Dan Heffez and Sean S. Kohles.

As the authors reported, the frequency of these fallen cerebellar tonsils (CTE)* was found “4 times more often” in neck pain patients who had experienced whiplash trauma versus neck pain patients that had not experienced recent trauma, when the FONAR UPRIGHT® MRI scanner was used.

The authors further reported, “CTE (tonsil ectopia) was found 2.5 times more often in the upright trauma vs. the recumbent group” if the patients were scanned in the FONAR UPRIGHT® Multi-Position™ MRI. In sum the anatomic origin of the patient’s whiplash symptoms was successfully visualized 2.5 times more frequently when the patient was scanned upright in the FONAR UPRIGHT® Multi-Position™ MRI than when he/she was scanned lying down in the conventional recumbent-only MRI.

The upright MRI examination, therefore, now makes it possible to provide definitive radiographic evidence and image characterization of the pathology giving rise to a patient’s whiplash symptoms so that it can be medically treated. For the first time, definitive anatomic evidence of the injuries sustained by whiplash victims in a motor vehicle accident can be provided. Currently, as the authors point out, some claim that patient whiplash pain is “non-pathologic chronic pain” engendered by “psychosocial factors such as litigation.” The newly published results from the FONAR UPRIGHT® Multi-Position™ MRI establish that this is not correct.

The July 2010 published report of 1200 neck pain patients that were examined in both the recumbent position in a conventional MRI and upright in the FONAR UPRIGHT® Multi-Position™ MRI establishes a “new standard of care” for victims of automotive whiplash injuries wherein the patients’ injuries can now be anatomically visualized and specifically defined so that the most expedient medical treatment can be provided.

Overall, the pathologic anatomy responsible for the patient’s whiplash symptoms was successfully identified in 23.3% of whiplash trauma patients (Table II, Brain Injury, July 2010: 24 (7-8):998) when the patient was scanned upright in the FONAR UPRIGHT® Multi-Position™ MRI. The cause of the patient’s symptoms was identified after a whiplash injury only 9.3% of the time (Table II) when the patient was lying down in a conventional recumbent-only MRI, a difference of 2 1/2 times or 150%.

Raymond V. Damadian, M.D., president and founder of FONAR said, “it has been published(1) that there are approximately 3,000,000 REAR IMPACT(2) crash related (or CAD(3)) INJURIES(2) in the U.S. annually. Accordingly, the publication by M.D. Freeman and co-authors in the July 2010 issue of “Brain Injury” has established that of the 3,000,000 motor vehicle CAD injuries occurring annually in the U.S. 700,000 (23.3%) would exhibit cranio-cervical anatomic changes associated with their symptoms when examined upright in the FONAR UPRIGHT® Multi-Position™ MRI, while only 279,000 would have their pathology detected by a conventional lie-down MRI. At the rate of 3,000,000 CAD whiplash injuries per year, 420,000 patients each year would have the pathology responsible for their symptoms go undetected if they were examined solely in a conventional recumbent-only MRI.”

Dr. Damadian further stressed, “the sudden rise in the incidence of patients suffering from the Chiari syndrome (cerebellar tonsil ectopia) is a fairly recent occurrence that needs to be addressed by both the medical and automotive professions. As Galasko et. al. from the University of Manchester, Salford, U.K., reported regarding the change in the incidence of whiplash disorders following the 1982 enactment of seat-belt legislation in the U.K. (J. Musculoskeletal Pain, Vol 8. (1/2) pgs 15-27), the incidence of whiplash associated disorders (WAD) rose “far in excess of general road traffic accident cases,” and as they also reported, “rose at an alarming rate”.

“Consequently,” Dr. Damadian stated, “it is very important that the approximately 3,000,000 people per year in the U.S. involved in the rear end auto collisions that give rise to whiplash injuries, receive an UPRIGHT® MRI examination soon after the accident. This will assure that a cerebellar tonsil ectopia has not resulted from the accident so that they can be protected going forward, and protected before they become symptomatic. If found to have CTE, they can then be warned by their physicians to exercise especial caution whenever driving and to have devices like the head restraint impact suppressor cushions installed (add On Head Rest, www.addonheadrest.com) to prevent the whiplash reaction from occurring again in the event of a collision.

“A real concern,” added Dr. Damadian, ” is that a subsequent auto-accident for a patient who had developed tonsil ectopia from a prior auto accident, but did not develop symptoms from the ectopia, can subsequently develop symptoms from even a MINOR subsequent accident. Wan, et. al. (Wan, M. J., Nomura, H., Tator, C. H. Neurosurg. 2008; 63: 748-753.), described a symptomatic “conversion” of previously asymptomatic Chiari Type 1 following MINOR(2) head and neck trauma” (Freeman, M. D. et. al. Brain Injury, July 2010: 24 (7-8):989.

Considering that long term studies have shown that some patients suffered frequent residual symptoms 17 years after the accident, mostly comprising neck pain, radiating pain and headaches, (Eur. Spine J. 2002; 11:227-34), this publication in “Brain Injury” clearly demonstrates the need and the superiority of the FONAR UPRIGHT® Multi-Position™ MRI for imaging patients involved in motor vehicle crashes that sustain whiplash injuries.

* Cerebellar tonsillar ectopia (CTE) constitutes downward displacement of the cerebellum of the brain into the opening in the bottom of the skull, the foramen magnum, through which the spinal cord exits the skull. The downward displacement can result in compression of the medulla of the brain, fourth ventricle and cerebellar vermis, giving rise to neck pain, chronic recurrent occipital headaches, upper extremity weakness and “drop attacks”. While afflicting a low percentage of Chiari 1 patients, such patients can be subject to instantaneous unpredictable losses of consciousness known as “drop attacks” in which the standing patient, without warning, suddenly collapses to the floor.

(1) Foreman, S. M., Croft, A. C. (eds) third edition. Whiplash injuries: The cervical acceleration/deceleration syndrome. Baltimore: Lippincott, Williams & Wilkins, 2001, Pg. 359.

(2) Capitalization added.

(3) Cervical Acceleration/Deceleration syndrome aka “whiplash”.

To obtain a copy of the article published in the peer-reviewed journal, “Brain Injury,” please contact FONAR at 631-694-2929×451 or by email at [email protected]. You may also use a search engine such as Google and search for the journal article entitled “A case-control study of cerebellar tonsillar ectopia (Chiari) and head/neck trauma (whiplash).

For investor and other information visit: www.fonar.com.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, pMRI™, Dynamic™, Multi-Position™, True Flow™, The Proof is in the Picture™, Spondylography™ Spondylometry™ and Upright Radiology™ are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company’s financial results may be found in the company’s filings with the Securities and Exchange Commission.

Home Homeowners Insurance coverage Online – The Web Proves To Be The Cheapest Source For Insurance

Posted on July 21, 2010 Written by Annalyn Frame

Find Out More At:

Employment Insurance Canada

Shopping for house insurance on-line is easy. There are a ton of websites that make it really easy to enter the right info in an effort to offer you an correct quote. The home coverage has less required information than the auto policy. Auto insurance coverage depends a lot on extensive driver and automobile information. The home-owner policy is dependent upon some fundamental information. The most important calculation is the actual sq. footage of your home. When you store online they’ll need this information.
Insurance coverage firms need this because they use various calculators to find out building costs per square footage. The net quote has a questionnaire that needs completed that may ask you another useful info that helps determine the replacement worth of your home. Air conditioning and fireplaces improve property replacement values. The dimensions of your deck or patio is also considered when determining the insurance amount. There are questions about your garage location. Completed basements improve the substitute worth and the net quote will typically ask you the share of your basement that’s finished.
Prior insurance coverage is important when looking for insurance protection for a house that you’ve got been residing in for a while. You will be asked about your present insurance. Having insurance is a must when comparison buying as a result of it is stability and credit score factor that can make the chance more acceptable for the insurance coverage company. If you’d like personal items insured on a rider of some sort then you will most certainly need proof of their value. Jewellery riders require latest appraisals and or receipts to prove their worth.
The online quote course of might reveal something about your present coverage that you simply were unaware of. You could find that after you complete a replacement cost estimator with a number of corporations that your private home is either under insured or over insured. This is one of the great benefits of shopping online. It allows you to do a few of your individual research. Store for home-owner’s insurance coverage online. You may be pleasantly surprised.

Click Here:

Payment Calculator Auto

Getting the Best Pet Insurance Quotes For Your Loved Ones

Posted on July 21, 2010 Written by Annalyn Frame

“Methods for Comparing the Best Pet Insurance Plans” OR “How to Comparing Pet Insurance Policies to Save Money”
If you’ve a pet then it is advisable to contemplate having pet insurance policy to ensure that they’re guarded in situation one thing takes place. Most persons will not think about getting this kind of insurance plan but it might truly help if they ought to go on the vet because they need medical procedures. If you’ve excellent puppy insurance coverage then you do not need to be concerned how you might be going to pay for there care. You can appear on the net and get low price cost-effective quotations with the vet pet direct. You ought to evaluate the rates and procedures to determine what fits you and your pets desires the most effective. You needless to say want to get a cheap insurance that you just can afford but make sure that it offers you enough protection so that you simply might be guarded. You can find websites that can support you by giving you several estimates and letting you assess and choose for your personal self which is the very best pet insurance policy. You may perhaps also want to speak for your insurance policies agent to see if there is really a lower price that you simply can use for having numerous insurances while using same business.

This is really a fantastic way to conserve on insurance policy that not quite a few persons know about or take benefit of. Remember that you simply pet can be a member of your family members and requires to get insurance so which you do not need to be concerned when the time comes that they require one thing main accomplished. It is also possible that they can get into an accident and planning for the vet can get pricey aspca pet insurance when a thing unexpected takes place. We treat our pets being a member of our family members so it can be significant that we give them insurance policy insurance coverage. You in no way know when anything might take place and you should take then to the vet. It really is get pricey rapidly especially if they need some kind of surgery. It really is easy to consider of our pets as invincible but just like us they are able to have wellness concerns too and you should be prepared for it. It can be better to plan ahead and have the protection you need when they turn out to be ill then wish you had accomplished a thing about it earlier.

Now quite a few insurance companies are offering dog insurance policy since they know how a lot your fury friend signifies for you. It is a excellent idea to start by looking on the internet and getting estimates so which you can get an reasonably priced rate that will fit into your budget. We generally tend not to consider having this kind of insurance plan but when something happens to them you will likely be glad you planned ahead with a pet insurance company. It is usually a excellent concept to talk with your insurance plan agent and see if they offer a lower price for multiple insurance plan plans. You may well discover that given that you have other insurances with them that you just qualify for a lower price and this can come in handy when you’re trying to acquire a prepare which is affordable. They is going to be able to provide you price and let you know the saving you will get for getting more than 1 prepare with them, whether it is really a home or ca that you simply have coverage on.

Automobile Insurance Guide

Posted on July 21, 2010 Written by Annalyn Frame

Everyone should have auto insurance for their personal or commercial vehicles . Auto Insurance will protect you against financial loss if you have an auto accident. Without insurance, a person would have the full cost of an accident to cover out of their own pocket . Insurance also protects you if an uninsured driver hits your car or if your car is damaged by other things, such as vandalism. Insurance will give you a peace of mind that in the event of an accident, you’ll be properly covered and safe from extreme money woes .

Auto insurance rates are based on many things. If you have any traffic violations your insurance rates will likely be higher. A lot of people don’t realize that your personal credit score can even affect your insurance rates . Auto Insurance, which is also known as car & vehicle insurance, is extremely important for any vehicle owner to have .

Auto insurance plans can vary as much as their companies. There are lots of things to weigh when you are choosing what policy is right for you. Auto insurance companies are there to help you sort through the car damage and remove some of the headaches and worries for you. Auto accidents aren’t something that we like to think about, but thinking ahead will help you and your auto rates in the long run.

Rates vary from day to day and you may receive a different quote on any given month. The only way to determine which company will give you the lowest auto insurance rates is to shop around and compare the different companies that are available in your area similar insurance policies. Rates might not be initially cheap, but with a little direction, you can ensure you receive quality auto insurance rates at an affordable price.

Individual Loans -Everything You Required To Know About It.

Posted on July 21, 2010 Written by Annalyn Frame

We try provide value through giving a top quality writings by giving knowledge from making webpages for exampleschool loan consolidation, school loans consolidation, school loan consolidations

It is a unsecured loan appropriate for any intention Like Education, Marriage, Medical Purpose, acquisition of Property or Assets, Repay old loans, Investments, Holidays, Gifts…etc. It is hassle free. No guarantors or safety /collateral required. Loans to salaried & self-employed. Special offers for Professionals like Doctors, Chartered accountants, Engineers etc.

What are the different types of personal loans available? Personal loans can be broadly seperated into income based and non income based. Income supported loans are given on the basis of income per month/per year for salaried and self employed respectively. Non income based loans also know as surrogate loans are given based on compensation track records of existing personal loans, car loans, home loans and Credit cards from approved banks. Minimum instalments paid/Months on books required is 9-12 months.

Different banks have dissimilar ways of calculating the eligibility. In the case of Salaried usually most of the banks might calculate qualification to be 1/1. 5 times of annual income. Factors such as existing loan liabilities, average bank balance, track record on existing loans, company profile & loan term also plays a role in deciding qualification.

In the case of Self Employed’s the eligibility would bet on the turnover, existing track record, net profit, cash credit /overdraft limit enjoyed, line of business, cash flow, bank statement, existing loan liability amongst other things. Usually the loan amount is limited at 1. 25 to 4 times of cash profit generated less existing liabilities or a certain percentage of revenue less existing responsibilities.

Loan tenure is the period within which the applicant wants to repay the loan.

Loans can be reimbursed from 1 year to 5 years. The rule of the thumb being longer the tenure higher would be the loan eligibility and vice versa. The age of the contender along with period of service left also manipulates the loan tenure.

Service charges, loan processing charges , bank charges are different traditions of describing the fees which the bank charges for processing and disbursing loans. It is deducted directly from the loan amount and is generally restricted to 2% to 3 % of the loan total. It is a one time cost.

WHAT IS THE LOAN PROCESS?

One can apply for a personal loan any time in anticipation of a fast, disturb free of charge and unsecured finance for any purpose. The verification process at residence and office is physically done within 2/3 days on acquiescence of all documents essential. There is a real-time credit check done to find out the credit history of the applicant in the bank applied as also other banks. If all the checks are positive the credit officer generally has either a telephonic or physical argument with the contender at his office/place of work.

Subject to the argument being affirmative the candidate has to sign an agreement and also hand over PDC’c(Post Dated Checks) or authorization for ECS(Electronic Clearing System). The applicant normally gets either a direct credit in his/her account or receives a Draft within 2/3 working days after accomplishing the agreement. The whole procedure may take 5/7 working days.

Owners Insurance coverage Coverage Needs: How To Determine Them

Posted on July 21, 2010 Written by Annalyn Frame

Learn More:

Commercial Van Insurance

For first time owners or for many who have by no means actually taken a critical look at their Householders insurance, figuring out what Owners insurance protection you need is usually a trying time. One of the crucial vital suggestions to remember when determining what type and how a lot Owners insurance coverage you need is to make this determination before you get started talking with an insurance coverage agent.
This can be very straightforward to get sucked into buying further insurance that you will by no means use by a sly talking agent on the phone. This doesn’t imply that you just shouldn’t take an insurance coverage agent’s recommendation in any respect, but simply be sure of a ballpark figure for the kind of protection and the amount of coverage you need and wish before you get started.
One of the first questions an insurance coverage agent will ask is the worth of the house being purchased. This merely means the fundamental exterior and interior worth of the house as it’s whenever you buy it, without belongings. Keep in mind that an insurance agent should ask particular questions relating to the outside of the house, resembling whether or not it’s brick, vinyl siding, wooden or a mixture, in addition to questions regarding a porch, deck or sunroom.
Insurance brokers should also be asking particular questions concerning the basic home equipment on the interior of the home, and can need to know how previous the plumbing and electrical system are, the air-con and heating unit, the appliances and can even ask questions on whether or not you could have costly counter tops or flooring, similar to granite or marble.
Remember that when you bought the home for a sure value, say $100,000, the Owners insurance firm could want to allot funds for the construction of the home to be anywhere from $10,000 to $forty,000 over the present appraisal and market value of the home, to deal with inflation. It’s as much as you to resolve if you wish to agree to those phrases, however remember that the worth of repairing these items within the residence will enhance through the years, and you don’t need to be left with not enough cash from the insurance firm to cover full substitute of your property at any given time.
In case you have purchased a home that may soon be transformed or reconstructed, chances are you’ll need to go ahead and add a considerable quantity to this portion of the insurance protection, that method if something occurs within the process of transforming or as soon as the home is transformed the whole cost of remodeling might be covered with out a problem. After all you’ll be able to all the time wait till the remodeling is completed to call and get a new worth quote, but it’s best to have the insurance coverage set in place prior to the completion of the remodeling.
The second main issue that must be considered in figuring out the amount of Homeowners coverage wanted is the interior worth of the products within the home. This is a tough process for some people who have not stored good receipts of purchases and that makes it easy for insurance coverage brokers to counsel more coverage than wanted in the inside goods department.
Earlier than calling for price quotes, it is best to take a seat down and try to briefly itemize the key purchases in your home, together with furniture, massive home equipment, and electronics. Many basic inside protection plans don’t cowl certain electronics reminiscent of computer programs or laptops, so remember to ask about laptop or laptop coverage if this is an item you’ve gotten in your home. As effectively, some insurance insurance policies will cowl jewellery but others would require a separate “special” interior Owners coverage, though adding this on would only price approximately $30-$eighty a yr for most jewellery owners.
The final determination for how much protection wanted ought to be location. This can be very important to consider whether or not you will need hurricane insurance coverage, flood insurance, wind and hail harm insurance, and even tornado insurance.
Bear in mind that even when you live in a hurricane zone, you may additionally be required to buy separate flood or wind insurance coverage, in case your property floods or the windows blow out from the storm. The same goes for tornado or earthquake insurance, as it’s possible you’ll be required to have separate amenities added to the policy to cowl wind injury or even flooding.

Check Out Now:

Woolwich Mortgages

This Week on ORLive: Live Thoracoscopic Maze Procedure to Cure Atrial Fibrillation

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: OR-Live, Inc.

New On-Demand and Live Surgery Video for the Week of July 19, 2010

WEST HARTFORD, CT–(Marketwire – July 20, 2010) – ORLive, the vision of improving health, presents a live thoracoscopic maze procedure to cure atrial fibrillation from PinnacleHealth. In addition to this live procedure, ORLive invites you to take part in the latest installment of the Virtual Brain Tumor Board, and to watch and learn from this month’s featured channel of no-visible-scar surgeries.

NEW ON ORLIVE

LIVE SURGERY VIDEO – Total Thoracoscopic Maze
Live Wednesday July 21, 2010, 7:00 PM EDT

The total thoracoscopic maze is a surgical procedure intended to permanently cure atrial fibrillation. This minimally invasive, beating heart procedure will be performed by Dr. Mubashir Mumtaz, Chief of Cardiothoracic Surgery at PinnacleHealth.

Viewers are invited to interact with the surgical team by submitting questions via the ORLive website. To learn more about this broadcast and to sign up for an e-mail reminder go to ORLive.com.

ORLIVE REFERRALS – Week of July 19, 2010
Each week ORLive highlights on-demand videos for our membership and visitors.

No Visible Scar Surgery Referral: Laparo-Endoscopic Single-Site (LESS) Procedure from Tampa General Hospital

CME Referral: Minimally Invasive Endoscopic Pituitary Surgery from Thomas Jefferson University Hospital

Viewer’s Referral: Whipple Procedure for Pancreatic Cancer from University of Maryland Medical Center

HIGHLIGHTS

NOW ON-DEMAND – The Anterior Supine Approach to Total Hip Arthroplasty
Now Available On-Demand

ORLive and Zimmer present a Total Hip Arthroplasty featuring the Continuum Acetabular System and the Fitmore Hip Stem. The surgery was originally presented live and was performed by Dr. Jonathan Yerasimides, University of Louisville Department of Orthopaedics, Louisville, KY and is moderated by Dr. Hari Bezwada, University of Pennsylvania School of Medicine Department of Orthopaedic Surgery, Philadelphia, PA. This video presents the entire surgical procedure, and provides an opportunity for firsthand insight of the safe and effective implantation and surgical procedure involved with the Continuum Acetabular System and the Fitmore Hip Stem.

This surgery video is available to members of the ORLive community, and members are still able to interact and ask questions via the ORLive website. Learn more about this broadcast at ORLive.com, and be ready to view this exciting procedure by activating your free membership to ORLive today.

PREVIEW – Prenatal Pediatrics
Premieres Tuesday, July 27, 12 PM EDT

Managing a high risk pregnancy can be difficult. NewYork-Presbyterian Morgan Stanley Children’s Hospital provides the maternal, fetal and pediatric expertise to care for high-risk pregnancies. NewYork-Presbyterian Morgan Stanley Children’s Hospital was one of only eight hospitals in the country ranked in each medical specialty measured by U.S. News & World Report, with distinct leadership in neonatology and pediatric cardiac surgery.

Watch the best in Prenatal Pediatrics July 27th at Noon.

Viewers of this video are invited to interact with the team via the ORLive website, and to join the community and receive regular updates from the NewYork-Presbyterian Morgan Stanley Children’s Hospital Center for Neonatal Pediatrics.

SUPPLEMENTAL CONTENT – VOX ORLive
Explore robotic assisted mitral valve surgery with cardiac surgeon Dr. Lynn Seto in the current episode of VOX ORLive, an audio podcast featuring the latest advancements in medicine, surgery, and medical technology.

About ORLive
ORLive is the leading provider of video communication channels to the healthcare community. Working collaboratively with hospitals and device manufacturers, ORLive produces and distributes customized, interactive, video programs that demonstrate the latest advances in medicine, surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 50,000 hours of programming each month. The ORLive network can be found on-line at www.ORLive.com.

Contact:

Bonnie Gergely
Communications Manager
(860) 953-2900
Email Contact

id=”nav_links”>

Nation’s Most Influential Eating Disorders Professionals Gather in Denver to Collaborate on Innovative Treatment Strategies

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: Eating Recovery Center

Treating Eating Disorders in Adolescents and Men Are Among Topics to Be Addressed at Rocky Mountain Eating Disorders Conference, August 13-14

DENVER, CO–(Marketwire – July 20, 2010) – Though statistics vary, most clinicians and dietitians agree — eating disorders are on the rise. To address this growing epidemic and discuss innovative treatment strategies, leading eating disorders professionals will gather in Denver August 13-14, 2010, at the 2^nd Annual Rocky Mountain Eating Disorders Conference.

Held at the Denver Marriott City Center in Denver, Colo., the conference is hosted by Eating Recovery Center, a national center for eating disorders recovery providing comprehensive treatment for anorexia and bulimia. CEUs are now available for several disciplines.

For the second consecutive year, the conference will focus on new treatment trends for anorexia nervosa, bulimia nervosa and EDNOS; as well as innovative strategies for addressing the complexities of these disorders.

“Collaboration within the eating disorders community ultimately leads to better outcomes for our patients,” said Kenneth L. Weiner, MD, CEDS, founding partner and medical director of Eating Recovery Center. “At the Rocky Mountain Eating Disorders Conference, individuals have the opportunity to learn best practices and treatment innovations from some of the leading minds in the field.”

Here is a brief sampling of sessions and speakers:

Key Ingredients for Creating a Center of Excellence: A Primer for Building a Successful Program, Kenneth L. Weiner, MD, CEDS

Escaping the Wilderness: Recovery from Anorexia, Emmett R. Bishop, Jr., MD, CEDS

Medical Complications of Anorexia Nervosa and Bulimia, Philip Mehler, MD, FACP, CEDS

The Willing and Able: Understanding the Adolescent Brain in the Treatment of Eating Disorders, Ovidio Bermudez, MD, FAAP, FSAM, FAED, CEDS

New Models of Family Therapy in the Treatment of Eating Disorders, Craig Johnson, PhD, FAED, CEDS

The Mindful Therapist, Carolyn Costin, MA, Med, MFT, CEDS

Registration is $150 and includes all sessions, dinner on Friday night, continental breakfast and lunch on Saturday, as well as refreshment breaks. Single-day registration is $75. Student-discounted registration is $100 and $50 for single-day attendance. Space is limited and registration prior to the event is recommended.

For more information or to register for the 2^nd Annual Rocky Mountain Eating Disorders Conference, visit Eating Recovery Center’s website or call 877-218-1344.

About Eating Recovery Center
Eating Recovery Center is a national center for eating disorders recovery, providing comprehensive treatment for anorexia and bulimia at the foot of the Rockies in beautiful Denver, Colorado. Facilities include a licensed behavioral hospital treating adults, an outpatient office, and an adolescent facility scheduled to open in November 2010. Our integrated program offers patients from across the country a continuum of care that includes inpatient, residential, partial hospitalization, intensive outpatient and outpatient services. Our compassionate team of professionals collaborates with treating professionals and loved ones to cultivate lasting behavioral change. For more information please contact us at 877-218-1344 or [email protected] or confidentially chat live on our website at www.EatingRecoveryCenter.com.

Contact:
Shannon Fern
CSG|PR
303-433-7020
Email Contact

Click here to see all recent news from this company

Medical Tourism Association Announces Strategic Initiatives for Much Awaiting Global Healthcare & Medical Tourism Congress 2010

Posted on July 20, 2010 Written by Annalyn Frame

LOS ANGELES, CALIFORNIA–(Marketwire – July 20, 2010) – The Medical Tourism Association, known for setting trends in the industry, announces new strategic initiatives under the theme progress in motion for global healthcare stakeholders, allowing them to discover & learn about intense topics of medical tourism, extending networking opportunities enhanced by dedicated sessions and creating knowledge sharing possibilities between government, insurance, healthcare and tourism professionals during THE World Medical Tourism & Global Healthcare Congress, taking place in LA from September 22nd – 24th. http://www.medicaltourismcongress.com.

“We recently announced our extensive agenda, today we are announcing the list of incredible speakers, coming exclusively with the sole purpose of providing a learning platform for industry stakeholders. We are particularly encouraged at the number of high level government officials who are attending the ministerial summit which indicates growing support from all sectors for medical tourism initiatives, especially ministers of health, tourism and economic development,” said Jonathan Edelheit, CEO of the Medical Tourism Association.

MTA team worked relentlessly this year to identify and invite top government officials from across the world, eminent professionals from US & International Insurance Companies, alongside some of the largest US and International Employers, on another hand, leading medical tourism experts and top global healthcare providers are revisiting the congress.

“Though we have received tremendous responses, we are receptive to have more top-notch experts and professionals to utilize the platform to share their knowledge, experience and expertise,” added Edelheit, inviting leading speakers to join congress by submitting white papers at http://www.medicaltourismcongress.com/en/speakers.html .

The congress is the biggest networking opportunity platform in the world for medical tourism and global healthcare related affairs. The addition of the “Buyers of Healthcare VIP Program” is also a unique feature which was added to create more interesting and one on one business meetings for all delegates and sponsors, bringing up to 200 employers, insurance companies, agents and medical tourism facilitators who are involved in or interested in patients traveling across borders for healthcare.

“Networking is the spirit of our congress. We realize that social media and electronic channels can’t replace one-on-one meetings. Last year we got incredible responses and many delegates mentioned networking alone provided ROI, while learning & sharing experience was nothing but overwhelmingly a delightful experience,” says senior meeting manager Silvana Maldonado, working exclusively for networking and meeting sessions.

While extensive agenda, green healthcare initiative, learning opportunities, networking possibilities and knowledge sharing are base of the congress, seasoned speakers are the main focus which makes this a comprehensive Medical Tourism Mecca gathering.

Karen Beyer – Director of Global Benefits, General Electric

Mr. Jose M. Loaiza – Senior Network Manager, Blue Shield of California

Premier W. McKeeva Bush – Premier, Cayman Islands

Joanne Armenio – Director, International Benefits, Kraft Foods

Bob Ihrie – Senior VP of Employee Rewards and Services, Lowe’s Companies, Inc.

Luis Fernando Moreas – Secretary of Tourism, Porto Alegre Brazil

Kathy Clark – Compensation & Benefits Analyst, Blackbaud, Inc.

Anthony Amato – VP Compensation & Benefits, Discovery Communications

Kevin M. Fickenscher, M.D., CPE, FACPE, FAAFP – Chief Strategy and Development Officer, Dell Services

H. E. Mr. Nasser Al Budoor – Director, Ministry of Health, UAE, International Relations & Health Affairs and Director of Health Minister’s Office

Cheryl Matheis – Senior Vice President for Health Strategy, AARP

Laila Al Jassmi – CEO, Clinical Support Services Sector, Dubai Health Authority

David M. Cheek – Vice President of Sales, Pan American Life Insurance Group

Dr. Shetty – Heart Surgeon of India & Founder of Hospital Investment Project, Cayman Islands

Michael Bertaut – Senior Healthcare Intelligence Analyst, Blue Cross and Blue Shield of Louisiana

Jeff A. Argotsinger – Director, Business Leader Medical Expense Group, Swiss Reinsurance Company

Dr. Hisham Diwani – General Manager, Health Insurance, Ministry of Health Syria

Bavdeep Singh – CEO, Fortis Healthcare India

Emilio M. Williams – Managing Director, Johns Hopkins Medicine International

Dr. Rick van Pelt – Director Global Programs, Partners Harvard Medical International

Mark Scotland – Minister of Health, Cayman Islands

Jonathan Hart – Chief Medical Officer, International Medical Group

Pamela Frank – International Health Services Coordinator, Children’s Hospital of Boston

Fred Hagigi – Director, Executive Education Programs Professor of Health Services, UCLA School of Public Health

MaryBeth Kramer – Sr. Manager, Global Benefits and HR Services Compensation and Benefits, Verisign

Shady Fawzy Nawar – Assistant Vice President – Provider Management, Qatar Insurance Company-Doha

Arthur L. Diskin, MD, FACEP – Vice President and Global Chief Medical Officer, Royal Caribbean, Celebrity and Azamara Club Cruises

Martha Turnbull – Travel Health Insurance Association of Canada

Linda Cote – AGB Sales Director Pacific Region, Aetna

Dr. Jeannette Takemura – Dean of School of Social Work, Columbia University

Alexander Sander Domaszewicz – Principal and Senior Consultant, Mercer Health & Benefits Services

Robert S. Shestack – WBC, Managing Director, National Sales Leader, Employer Benefits Business, Marsh U.S. Consumer, a service of Seabury & Smith, Inc.

Brad Cook – International Patient Department, Hospital Clinica Biblica, Costa Rica

Renee-Marie Stephano – President, Medical Tourism Association

Jonathan Edelheit – CEO, Medical Tourism Association

Ralph Lawson – Executive Vice President and Chief Financial Officer
Baptist Health South Florida

Greg Carlson – Assistant Professor, University of Alabama, Department of Health Services

Jason B. Krouse – Executive Vice President, Univers Workplace Benefits

William Cook – International Patient Department, Hospital Clinica Biblica

Dr. Prem Jagyasi – MD & CEO, ExHealth Dubai

Tom O’Hara – President, Surgical Trip LLC

Dr. Antonia Arnaert –Vice-President, Debson Medical Tourism

Dr. Narottam Puri – President, Medical Strategy & Quality, Fortis Healthcare

Wouter Hoeberechts – CEO, WorldMed Assist

Doug Wojcieszak, Founder, Sorry Works!

Richard Polak, President & CEO, IBIS Advisors

Derrell Connor, Account Executive, M3 Insurance Solutions for Business (M3)

Tom Hamilton – President, Carolina Benefit Designs

Daniel Friedland – MD, Founder & CEO, SuperSmartHealth

Jason Woods – Fairmont Specialty Group

Sonia Roschnik – Operational Director, NHS Sustainable Development Unit, UK

C. Duane Dauner – President, California Hospital Association

Stephen Hartigan – Chief Executive Officer, InterGlobal Insurance Company Ltd. (IGIC)

Peter Lozier – Executive Vice President Sales, Marketing and Provider Relations, CMN Inc.

Dr. Myles Druckman – Vice President Medical Services, Americas Region
International SOS Assistance, Inc

Dean Stone – Manager Workers Compensation and Governance, National Australian Bank

Stuart Rowley – CEO, Prince Court Medical Center, Malaysia

To view a full list of speakers please CLICK HERE or go to http://medicaltourismcongress.com/en/speakers.html.

Join us for the VIP After Party

The World Medical Tourism & Global Healthcare Congress is also known for its networking cocktail receptions following the general sessions. On Wednesday, September 22, 2010 all registered delegates will be invited to share in an entertainment filled networking session jointly held with the Employer Healthcare Congress where up to 1000 employers, insurance agents, brokers, consulting firms and healthcare leaders will finishing up their three day congress event on the Green Circle Terrace. For more information about the VIP After Party, please go see the video at http://www.medicaltourismcongress.com/en/vip-party.html .

Additional Giant Leaps for 2010

The World Medical Tourism and Global Healthcare Congress includes two additional conferences which are the Expatriate Healthcare, Travel Insurance and Global Health Insurance Conference, http://www.expatriateconference.com and the Sustainable Healthcare and Hospital Development Conference, http://www.healthcaredevelopmentconference.com . Speakers listed above are from all three conferences.

The Medical Tourism Association™ (Global Healthcare Association) is the international non-profit trade association for the medical tourism and global healthcare industry made up of the top international hospitals, healthcare providers, medical travel facilitators, insurance companies, and other affiliated companies and members with the common goal of promoting the highest level of quality of healthcare to patients in a global environment. http://www.medicaltourismassociation.com.

Marketing & PR by ExHealth / www.ExHealth.com

APHL Assists Haiti to Rebuild Devastated Lab System

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: Association of Public Health Laboratories

SILVER SPRING, MD–(Marketwire – July 20, 2010) – A critically needed modular laboratory facility is en route to Port-au-Prince thanks to a collaboration between the Association of Public Health Laboratories (APHL) and International Relief Solutions, LLC (IRS). The APHL Haiti Field Laboratory Support Team provided technical assistance to International Relief Solutions, LLC (IRS) in planning and design of the new laboratory, which will replace the temporary tent facility that has served the nation’s largest hospital since the January earthquake.

The 24′ by 36′ modular laboratory will be erected at L’Hôpital de l’Université d’État d’Haïti (HUEH). Since the earthquake, the number of patients being treated at HUEH has tripled from 14,000 per month to almost 42,000 thus increasing demands for laboratory testing. Due to extremely high temperatures and no air conditioning in the tent, automated testing requiring cooler temperatures, such as hematology and blood chemistry, are being run manually. The result is that the current testing capacity is only 25% of the daily demand. The modular lab facility is designed with infrastructure for work benches, heating, ventilation, plumbing and electrical services. With direct hookup to electrical and water supplies, the laboratory building will have the air conditioning necessary to meet the requirements of the many intricate and delicate tests that the laboratory technicians on scene perform routinely. The lab will arrive with the electrical system and plumbing pre-installed allowing for a quick start-to-finish set up of approximately four days.

APHL Senior Technical Consultant and Team Leader for the APHL Haiti Field Laboratory Support Team, Dave Doherty, coordinated this effort from start to finish. Following the earthquake, the Centers for Disease Control and Prevention requested and authorized Doherty and his team to assist all of the public health network laboratories in Haiti in getting testing services back up and running to support the enormous demands for medical care and treatment.

Better lab facilities will improve testing services and also enable laboratory technologists to get back to work. According to Doherty, “Many well-trained technologists in Haiti are unable to work and provide testing services because of the loss of laboratory facilities to earthquake damage.”

It could be years before the permanent structures are rebuilt; the new modular lab serves as a long term solution. This initiative was a success due to the collaboration of willing and committed partners, each of whom brought essential resources and expertise to assure an effective solution for meeting a critical need in Haiti. Lives will be saved and illnesses treated effectively because of the efforts of APHL, IRS and CDC. Doherty modestly explains, “We were able to come through. APHL has always come through in Haiti.”

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Contact:
Michelle M. Forman
240.485.2793
Email Contact

Click here to see all recent news from this company

Amazing Charts Emerges as EHR of Choice for Small Practices

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: Amazing Charts

Used by 3,600+ Practices and Growing by 70+ Practices Monthly

SAUNDERSTOWN, RI–(Marketwire – July 20, 2010) – For the small practice healthcare provider, selecting an Electronic Health Record (EHR) system can be a daunting task, with more than 300 vendors, complicated pricing, and products that are impossible to evaluate for usability, effectiveness, and implementation times. Oftentimes this leads to buyer’s remorse and later switching to another EHR.

Due to its industry-leading user satisfaction ratings in multiple studies, $995 price tag, and three month risk-free trial offer, Amazing Charts has quickly emerged as the EHR-of-choice for small practices.

Founded and designed by physician Jonathan Bertman, MD, FAAFP, specifically for offices with three or fewer providers, Amazing Charts enables rapid documentation of patient encounters, with fewer errors, faster coding, and ePrescribing. In most cases, no training is required for first-time users. Amazing Charts is a CCHIT Certified® 2008 Ambulatory EHR additionally certified for Child Health.

Gordon Comstock, MD, practices family and geriatric medicine in Arcade, New York, a low-income area of the state. His medical practice has over 3,000 patients, many of who are elderly and on fixed incomes.

At his former practice, Dr. Comstock saw his colleagues “spend nearly $280,000 on an EHR system they found to be unwieldy and difficult to use.” He notes that there were way too many little pull-down menus and data fields, forcing him to “dictate notes anyway because [he] couldn’t document notes during a visit.” Additionally, the practice had to hire a full-time person just to scan paper documents like referral letters and lab reports into the EHR.

Today he uses Amazing Charts to run his entire office.

Says Dr. Comstock, “Amazing Charts is the closest an EHR can get to how a family doctor likes to generate a note. Many of the referral letters I see from specialists are indecipherable because they are generated by EHRs that don’t communicate what the specialist actually saw and thought. Amazing Charts always allows me to express myself in a way that captures not only the data points, but also the subjective narrative of my thoughts and observations.”

Another practice, Community Medical Group in Downey, California, had a different set of problems. After decades in operation, the three physician practice had amassed over 7,200 patients and their charts had become a significant obstacle to keeping the office running.

According to Dr. Martin Sechrist, “specific charts were hard to track down, the filing backlog was lengthy, and it was often difficult to match charts with filings.”

With Amazing Charts, every patient has an electronic health record that can be accessed from any computer in the office, remotely, or via a simple iPhone app.

Says Dr. Sechrist, “Amazing Charts mirrors the way we conduct patient encounters, and makes immediately available all patient demographics, imported items, and a patient summary of current issues, medications, and prior encounters. Even outside laboratory results are imported directly into the electronic medical record!”

Amazing Charts automatically generates an electronic “super-bill” whenever a note is signed, and records are backed up daily in a secured database on-site.

Amazing Charts V5 can be downloaded for a free, three-month trial at http://www.amazingcharts.com.

About Amazing Charts
AmazingCharts.com provides Electronic Health Record (EMR) software and services to small and medium sized healthcare practices. Used by more than 3,600 practices in the U.S., Amazing Charts has been growing by over 70 new practices each month, based on its high ratings for quality, price, support, ease of use, and impact on productivity. For more information visit www.amazingcharts.com or call 1-866-382-5932.

Click here to see all recent news from this company

Pregnancy and Pre-Existing Diabetes

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: American Diabetes Association

Diabetes Forecast With Information for Mothers-to-Be

ALEXANDRIA, VA–(Marketwire – July 20, 2010) – Pregnancy is a time of wonder and amazement — and for women with pre-existing diabetes, it is also a time for very extremely careful (and sometimes baffling) disease management. How do you plan for this? What risks are involved? What can you expect? The August issue of Diabetes Forecast, the consumer magazine of the American Diabetes Association, features articles about pregnancy with pre-existing diabetes to help you. With good care and planning, says Diabetes Forecast, women with either type 1 or type 2 diabetes can have safe pregnancies — and healthy babies.

Planning starts now. If you have diabetes and want to become pregnant, the first step should be visiting your doctor — or several doctors. Depending on your diabetes management, you may want to see an endocrinologist in addition to your ob-gyn for a pre-conception visit. When choosing your doctors, keep in mind that you may have appointments as often as twice a week, so try to find a physician that you are comfortable with and whose office you are comfortable getting to.

While pre-existing diabetes automatically puts your pregnancy in the high-risk category, healthy habits can lower the chance of problems for both mother and child. First and foremost, keep your blood glucose in check — in general, your A1C should be below 7 percent before you conceive. Your health care team may also want to discuss your weight, use of prenatal vitamins and other supplements, the status of any diabetes-related complications, and your current medications (such as ACE inhibitors or statins, which are not considered safe for use in pregnancy). Polycystic ovary syndrome is associated with type 2 diabetes, so for some women with diabetes, asking about fertility treatments may also be in order.

Once you become pregnant, your body’s changes can make blood glucose levels go from one extreme to the other. “I spent the entire first trimester with my face buried in the fridge,” says Kerri Sparling, 31, who has type 1 diabetes and whose daughter was born in April. “I was low all the time. It wasn’t until probably the second trimester that the insulin resistance kicked in. Everything I ate, the insulin didn’t cover it.” As your body changes through your pregnancy, so will its reactions to the elements you normally use to manage your blood glucose, so be prepared to communicate with your health care team often and make any necessary adjustments.

From pre-conception planning to integrating diabetes management into your birth plan and facing post-partum depression, having a baby can seem like an overwhelming task for women with diabetes, and yet, many women with diabetes find they have the best glucose control of their life during pregnancy. “This was so, so important to me that I was willing to do whatever to make sure she came out right,” says Sparling. “It’s so worth it.” Find more advice, explanations and insight about what to expect in the August issue of Diabetes Forecast.

This issue of Diabetes Forecast also features:

A Birthday Challenge: Marking 40 years with 40 races for ADA’s Team Diabetes

Drinking Calories: How you hydrate yourself makes a difference

A Serious Subject: Dealing with erectile dysfunction

Diabetes Forecast has been America’s leading diabetes magazine for more than 60 years, offering the latest news on diabetes research and treatment to provide information, inspiration and support to people with diabetes.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact:
Dayle Kern
[email protected]
(703)549-1500 x2290

id=”nav_links”>

Patient Channel and Newborn Channel Further Expand Ad Sales Team With Addition of Pharmaceutical Ad Sales Pro, Dammand Cherry

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: Interactivation Health Networks

Formerly With USA Weekend Magazine, Dammand Cherry Joins Interactivation Health Networks as Account Executive, Ad Sales

NEW YORK, NY–(Marketwire – July 20, 2010) – Interactivation Health Networks, parent company of the Newborn Channel and Patient Channel, the nation’s most comprehensive in-hospital TV networks, today announced that Dammand Cherry will serve as Account Executive, Ad Sales, for both channels.

Dammand’s extensive experience in pharmaceutical media sales and agency management will provide advertisers with an additional point of contact intimately familiar with the pharmaceutical industry’s advertising needs and expectations.

“The pharmaceutical industry has always been an important partner for the Patient and Newborn Channel,” said Suzanne Fleming, SVP of Sales at Interactivation Health Networks. “Dammand’s experience in the health media space shows our continued commitment to personally cater to this industry, making it even easier for them to achieve a focused and effective out-of-home advertising campaign. We are thrilled to have him on-board as demand for both networks continues to grow.”

Newborn Channel and Patient Channel provide marketers with unparalleled access to their target consumers in a highly trusted environment.

About Interactivation Health Networks
The Patient Channel and The Newborn Channel are the most comprehensive in-hospital TV networks. Delivered directly to patient rooms and waiting areas, the Channels provide viewers with original, award-winning health programs and advertisers with the unique ability to integrate brand messaging with content that is compelling and endorsed by healthcare professionals. The Newborn Channel broadcasts baby care and postpartum programming for new parents, reaching 60% of new moms. The Patient Channel features both condition-specific and preventative health programming to empower and inform patients. The channels are currently available in over 2,700 hospitals nationwide. For more information, visit http://interactivation.com/news/index.php/interactivation-health-networks/.

Media Contact Information:
For more information or to speak with an executive of the company, please contact:

Wendy Simmons or Josh Kail
Vendeloo
Ph: 718.522.9873
E-mail: Email Contact or Email Contact

Seegene’s New Magicplex(TM) Sepsis Test Indentifies Over 90 Indicators for Deadly In-Hospital Disease

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: Seegene

Multiplex Real-Time PCR Test Simultaneously Screens for Gram (+), Gram (-), Fungi and Antibiotic Resistant Genes to Deliver Highly Accurate Results Within Three Hours

ROCKVILLE, MD and SEOUL, KOREA–(Marketwire – July 20, 2010) – Seegene today announced the availability of Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. Magicplex Sepsis provides a novel and fast-acting diagnostic technique for hospitals to simultaneously verify a complex range of targets that indicate sepsis, the leading cause of death in non-coronary intensive care units worldwide. Seegene’s Magicplex Sepsis will be introduced at the 2010 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), booth # 1800.

Sepsis is a deadly disease that leaves no clear track back to initial indications, which could include gram-positive bacteria, gram-negative bacteria or fungi. The results are devastating: the annual incidence rate of sepsis has increased 91.3 percent over the last 10 years, and every hour 25 people in the United States die from severe sepsis. One of every three patients who develop severe sepsis will die within a month. Severe sepsis, the leading cause of death in the non-coronary intensive care unit, takes more lives than breast, colorectal, pancreatic, and prostate cancers combined.

The medical challenge to be overcome is to determine the correct treatment of sepsis within the first hours of the onset of the disease. Currently physicians and clinicians have little option but to run several available molecular diagnostic tests that offer little confidence that the results will definitely identify the presence of sepsis in a patient. The alternative to these relatively quick tests is a multiple-phase blood culture test, which is a time-consuming process, or current multiplex PCR with limited range of pathogen targets and poor test specificity.

Seegene’s Magicplex Sepsis Test is a sharp break from this mold. Magicplex Sepsis is a real-time detection test that quickly and comprehensively determines the levels of suspected targets in a patient’s blood sample, and identifies drug resistant genes to better inform a diagnosis. The speed, accuracy and price of the Magicplex Sepsis Test will enable doctors and clinicians to quickly provide an appropriate treatment to head off the deadly disease.

The Magicplex Sepsis Test simultaneously screens for over 90 sepsis-causing pathogens: over 70 Gram (+) (30 Staphylococcus, 40 Streptococcus, 3 Enterococcus); 12 Gram (-); 6 Fungi; and 3 antibiotic resistant genes (mecA, vanA, vanB) can also be discriminated. The Magicplex Sepsis Test requires less than 1ml of patient’s whole blood and provides test results within three hours (after extraction). The test’s unique performance is a function of separate screening and identification steps. For example, when screening for over 90 sepsis-causing pathogens, the identification of exact pathogens can be carried out without starting from blood collection. 30 different pathogens are organized in different panels for identification and it only takes 40 minutes to detect.

“The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapid and cost-effective sepsis diagnosis,” said Jong-Yoon Chun, chief executive officer of Seegene. “In treating sepsis, time and accuracy are demanded. Every hour of delay in giving patients the correct antibiotics results in an 8% increase in the mortality rate.”

“For doctors and clinicians performing faster diagnosis than by blood culture is a dream come true. By enabling doctors to make accurate diagnosis faster, Magicplex Sepsis can lead to improved patient outcomes in health care settings worldwide,” said Hong-Soo Kim, MD, Department of Internal Medicine, Institute of Gastroenterology, Soonchunhyang University College of Medicine, Korea.

Magicplex tests are based on Seegene’s proprietary READ™ technology, which combines the advantages of multiplex in a real-time system. The result is a molecular diagnostic testing system that provides higher specificity and sensitivity over currently available PCR systems.

The READ technology of Magicplex tests is a departure from probe- and primer-based PCR methods to produce false-free detection. Magicplex test works in a simple two-step process: first specifically amplifying the DNA sequence of target pathogens, then simply reading those signals using any real-time PCR instrument.

Magicplex Sepsis Test will not be available in the USA until regulatory clearance.

About Seegene

Seegene, Inc. is the leading biotechnology company developing, manufacturing and marketing innovative molecular diagnostic products. The company’s proprietary technologies in both PCR and Real-time PCR named ACP™, DPO™, and READ™, set a new solution for high-throughput and simultaneous multi-pathogen detection called “multiplex PCR.” The novel Real-time PCR technology, READ™, overcomes the limitations of conventional Real-time PCR, providing dramatic improvement in sensitivity and specificity. Seegene holds three novel Molecular diagnostic platforms: Seeplex^® system adapting DPO™ Technology, Anyplex™ and Magicplex™ systems that are Real-time PCR detection platforms adapting DPO™ and READ™ technologies. Seegene’s products detect multi-pathogens with great reliability and throughput, ultimately providing the most economical basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology using the innovative proprietary technologies.

For more information please visit www.seegene.com or call +301-762-9066.

Contacts:
Miyoun Lee, MSc
Seegene Inc.
301-762-9066
or
Constantine Theodoropulos
Base Pair Communications
617-816-4637

American Health Expands Disease Management Offering by Targeting High-Risk Population and Addressing Chronic Pain

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: American Health Holding, Inc.

WORTHINGTON, OH–(Marketwire – July 20, 2010) – American Health Holding, Inc., a multi-URAC accredited medical management service provider, today announced the expansion of its Disease Management (DM) program to provide more program options to help clients contain costs while assisting individuals managing a chronic condition.

“We heard our customers’ request for a DM program that addresses those most in need of health management intervention,” states Paul Lavin, American Health’s President. “We felt our new High Risk Disease Management program was a solution. While American Health’s Comprehensive DM program targets approximately 20% of a client’s population, the new High-Risk program reaches the 5.5% who are at the highest risk for incurring large health care claims.”

In March 2009, American Health launched its new Population Health Management (PHM) program. Comprised of both DM and Lifestyle/Wellness components, PHM takes aim at helping benefit providers address rapidly rising health care costs while assisting individuals in achieving optimal health. At the start of the program, DM addressed seven chronic conditions for which evidence-based guidelines are established to impact health and measure improvement: asthma, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, diabetes, hyperlipidemia, and hypertension.

“In addition to introducing our high-risk program, we have added chronic pain as the eighth condition that we manage,” notes Anne Klie, Director of Product Development and Marketing. “We recognized that by using our proven behavioral assessment and modification tools we can make a difference in the lives of people suffering from low back pain and osteo- and rheumatoid arthritis.”

Earlier this year, American Health’s participant satisfaction survey revealed that 100% of first-year participants would be likely to recommend the program. “We are pleased with our preliminary outcomes, and we look forward to continue enhancing the program experience for our members,” adds Lavin.

About American Health Holding, Inc.
American Health Holding is a single-source provider of medical management services that supports millions of members across the health care continuum. The multi-URAC accredited organization has been helping clients to maximize cost savings while ensuring the quality and appropriateness of care since 1993. American Health provides a level of flexibility that supports integrated solutions for creating healthy outcomes. For more information about American Health visit the Web site: www.AmericanHealthHolding.com.

Contact:
Joanna Callihan
Marketing Manager
American Health Holding, Inc.
(614) 818-3222 Ext. 1431
[email protected]

Click here to see all recent news from this company

CLSI Publishes Performance Standards for Antimicrobial Susceptibility Testing; June 2010 Update

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: Clinical and Laboratory Standards Institute

WAYNE, PA–(Marketwire – July 20, 2010) – Clinical and Laboratory Standards Institute (CLSI) recently published “Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update)” (M100-S20-U).

This update includes:

New interpretive criteria for doripenem for Enterobacteriaceae

Revised interpretive criteria for ertapenem, imipenem, and meropenem for Enterobacteriaceae

Guidance for use of the modified Hodge test (MHT) with revised interpretive criteria for carbapenems

Jean B. Patel, PhD, D(ABMM), Deputy Director, Office of Antimicrobial Resistance, Centers for Disease Control and Prevention, and member of the subcommittee that developed the update, says, “Carbapenemase-producing Enterobacteriaceae are a significant infection control concern, and rapid laboratory detection of isolates that may carry these resistance mechanisms is an important step in preventing transmission. Since these isolates will test nonsusceptible (ie, intermediate or resistant) to one or more of the carbapenem agents using the revised breakpoints, it will be easier for laboratories to identify these isolates and to report their findings to hospital infection preventionists.”

Michael N. Dudley, PharmD, FCCP, FIDSA, Senior Vice President, Research & Development and Chief Scientific Officer, Mpex Pharmaceuticals, Inc., and member of the subcommittee that developed the update, agrees, “It was important to provide further direction to laboratories on detection of isolates with reduced susceptibility to carbapenems. Unfortunately, there are no reliable clinical studies that allow assessment of the clinical response to treatment of carbapenem-producing strains to carbapenem antimicrobial agents. However, studies in animal models indicate that the minimal inhibitory concentration (MIC) is the best predictor of antibacterial effects. The new MIC breakpoints, coupled with US Food and Drug Administration (FDA)-approved dosage regimens used frequently in the clinic, provide for a better probability of attaining pharmacokinetic/pharmacodynamic exposures associated with antibacterial effects in vivo. The new intermediate and resistant breakpoints for carbapenems also ‘capture’ a majority of isolates that produce carbapenemases that can be confirmed using the MHT, if needed.”

He adds, “This new update will help laboratories improve quality and provide timelier reporting of susceptibility results.”

Tracy Dooley, MLT(ASCP), CLSI Standards Administrator, explains the importance of publishing a midyear update to the well-known annual antimicrobial susceptibility testing (AST) breakpoints, saying, “In an effort to disseminate information to users in a timelier manner, the Subcommittee on AST decided to publish a midyear M100 supplement with the new/revised carbapenem interpretive criteria for Enterobactericeae. This midyear publication allows laboratories to begin to initiate the implementation of these changes. One of the benefits of the new interpretive criteria is that nearly all carbapenemase-producing isolates will test nonsusceptible to one or more carbapenems. This alleviates the need to perform initial screening and confirmatory testing (MHT) for routine patient testing. Historically, each complete blood count (CBC) instrument/reagent manufacturer developed its unique approaches to system validation and performance claims. This standard will help create better standardization among manufacturers, as well as assist practicing laboratories in developing consistent testing.”

The tables in this M100-S20 June 2010 Update are to replace Tables 2A and 2A-S2 in
Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (M100-S20) (January 2010). For other tables referenced in this update, please see M100-S20 (January 2010).

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information on CLSI, visit the CLSI website at www.clsi.org or call 610.688.0100.

Contact:
Amanda Holm
Senior Marketing Manager
Phone: 610.688.0100 ext. 129
E-mail: Email Contact

Click here to see all recent news from this company

iData Research: Rapid Growth of NuVasive’s XLIF(R) for the Treatment of Back Pain Fuels MIS Spinal Fusion Procedures to Triple by 2016

Posted on July 20, 2010 Written by Annalyn Frame

VANCOUVER, BRITISH COLUMBIA–(Marketwire – July 20, 2010) – According to new spinal implant reports by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the U.S. market for spinal implants is estimated to exceed $8 billion by 2016, while the MIS spinal implant market is estimated to reach over $3 Billion. In addition, rapid growth in artificial disc use will fuel the spinal motion preservation market to increase six-fold by 2016.

While many have predicted the cannibalization of spinal fusion procedures by motion preservation, iData’s report reveals healthy growth in the fusion market driven by a consistent rise in minimally invasive surgical (MIS) interbody procedures, the market for which will triple by 2016.

“Lateral lumbar interbody fusion, such as NuVasive’s XLIF^(R)(NASDAQ:NUVA), is the most rapidly increasing MIS interbody fusion procedure,” says Dr. Kamran Zamanian, CEO of iData.

Despite growth in spinal fusion, the competing spinal motion preservation market, which includes cervical artificial discs, is also expected to experience strong growth. Reimbursement policies for motion preservation devices are expected to continue to drive this market.

“The cervical artificial disc segment is aiding strong growth in the spinal motion preservation market,” says Dr. Zamanian. “Companies such as DePuy, Medtronic and Synthes are leading the market, while many competitors such as Cervitech, Globus, NuVasive, SpinalMotion, and Zimmer are expected to emerge into this segment in the next few years.”

iData’s global report series on the “Markets for Spinal Implants & VCF 2010” and the “Markets for Minimally Invasive Spinal Devices 2010” also covers VCF, spinous process fixation, facet fixation and MIS pedicle screws.

For more information, register free on iData’s website at: http://www.idataresearch.net/idata/registration.php

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies.

Seniors In Touch Announces Patent Award

Posted on July 20, 2010 Written by Annalyn Frame

SOURCE: TrinityCare Senior Living, Inc.

FRIENDSWOOD, TX–(Marketwire – July 20, 2010) – TrinityCare Senior Living, Inc. (OTCBB: TCSR), today announced they have been awarded a patent for the Company’s interactive family communication system, Seniors In Touch (SIT).

“Seniors In Touch allows senior adults to use a simple touch screen computer system to send and recieve video messages, email, pictures, and other digital media,” says Brian Lang, Chief Executive Officer of SIT. “Family and friends from across town or across the nation can share messages, memories, and daily activity using the Internet, hand held technology, and other creative media. The award of this patent recognizes SIT’s technical and social media innovation.” The Company previously announced the implementation of this technology together with CoVideo Systems, a leader in providing video emailing, conferencing and presentation tools.

About Seniors In Touch

Seniors In Touch is an interactive communication system for senior adults and their families. Utilizing the latest in touch screen computing combined with established communication tools, seniors will be able to send text and video messages to persons in their contacts via a secure, user-friendly, touch interface. A family member serves as the administrator of the Seniors In Touch account to provide approved and safe interaction for the senior adult. Seniors In Touch will also provide photo-sharing services and limited web access for news, weather and sports that is approved by the administrator. The platform will also provide executive directors of senior living facilities a platform in which to communicate with both the senior adults and their families. For more information please visit www.seniorsintouch.com.

About TrinityCare Senior Living, Inc.

TrinityCare Senior Living (“TrinityCare”) develops, owns, and manages quality senior living facilities that focus on enriching the faith of the residents and providing state-of-the-art independent living, assisted living, memory care and adult day care services in a single location. The Company partners with local churches and developers for each facility and offers a wide range of both community and personal services to residents. TrinityCare is a rapidly growing company with three successful facilities currently operating in Texas and Tennessee. Near-term expansion plans target the Southeastern part of the United States. For more information please visit www.trinitycare.com.

TrinityCare is headquartered in Friendswood, Texas (Houston metropolitan area) and its common stock trades on the OTC Bulletin Board under the symbol “TCSR.”

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company’s periodic filings with the Securities and Exchange Commission.

For Additional Information, Please Contact:
Brian Lang
CEO
[email protected]

Life Insurance coverage And Crucial Sickness Insurance. Cancer Assessments To Enhance Girls’s Premiums

Posted on July 20, 2010 Written by Annalyn Frame

Learn More:

CGU Insurance

Ladies, in case your mother or some other female blood-line kin have a history of breast or ovarian cancer then from next 12 months onwards, you would face larger insurance premiums. You can even be refused cover altogether.
When these girls apply for life and important illness cover, the insurance coverage business desires to ask them whether they have been tested for the gene mutations BRCA1 or BRCA2. These are the gene issues that increase the possibilities of them developing these cancers. However earlier than the insurance coverage companies can ask these questions on their utility forms, they need to get approval from the Genetics and Insurance coverage Committee, the physique that advises the Authorities on these and similar issues.
Within the coming months the Affiliation of British Insurers (ABI) might be requesting the Committee for authority to ask women whether or not they have been tested optimistic for BRCA1 or BRCA2 gene mutations. These are the mutations which are present in 1 in 10 of newly diagnosed instances of ovarian most cancers and 1 in 20 of latest cases of breast cancer. Roughly 1 in 850 ladies in Britain inherit a faulty BRCA1 gene and of these, 14 – 18% will develop breast most cancers throughout of their lives.
On the internet web site for the Genetics and Insurance coverage Committee we found a notice saying, ” The Committee expects that the Association of British Insurers will submit in late 2006/2007 four revised and updated functions for the use of adversarial outcomes from the predictive genetic exams of the BRCA1 and BRCA2 genes (breast/ovarian most cancers) in serving to to determine insurance coverage premiums for all times and critical illness insurance coverage”.
Up to now, software varieties issued by British insurance coverage companies are only allowed to ask for the results of predictive exams for Huntington’s disease. Even then, the query can only be requested when the applying is for more than £500,000 of life insurance cover or mote than £300,000 for essential sickness insurance coverage or over £30,000 for fee protection insurance. This rule is ready under an agreement entered into by the insurance coverage trade which is because of expire in 2011 however the Chairman of the ABI’s Genetics Working Social gathering, Harpal Karlcut, is reported within the trade insurance coverage journal “Cowl”, as saying: –
“We wish to get approval for the breast most cancers test by the end of the 12 months”, including, “The two breast cancers are the next circumstances that we are going to have a look at however after that we do not see the necessity to have a look at other conditions. We do preserve an eye fixed out for what ailments could come up in the future however there may be nothing else on the horizon”. We add one other vital rider – but!

Check Out:

Tax Credits Helpline

Figuring out how much Auto Insurance coverage Protection you Want

Posted on July 20, 2010 Written by Annalyn Frame

Go Here:

GIO Insurance

1: Different Celebration:
Auto Insurance Bodily Harm (BI) Liability and Property Injury (PD) protection is Legally required in most states today. (BI & PD) Most people perceive that they need BI and PD, but they do not know the way to decide how a lot protection they need.
Do that easy question: What in case your car was concerned in an auto accident tonight where heaven forbid, another person was injured or killed? Bear in mind, the whole lot you own is within the again seat of the automotive with you and is in danger in a lawsuit! So, what do you think their household would sue you for? $15,000? $25,000? $100,000 and even maybe a Million dollars! Where would you get the cash to pay them?
Perhaps the Fairness in your Home would help? How about your Savings and/or Investments? You might even have as much as 25% of your wages hooked up to pay the award in most states! Are you prepared to sacrifice all the things you personal to pay an award as a result of this accident? If not, learn on for the way to choose the auto insurance coverage you need.
2: You and Your Family:
Now let’s turn the above accident around. For some unlucky motive, you or a beloved one is the one who’s injured or killed in an auto accident. Where would you get the money if the person who hit you did not have auto insurance or not sufficient auto insurance? Medical bills will be coated if in case you have health insurance. However health insurance doesn’t cover lack of life, ache & struggling or everlasting disability.
Possibly you’ve gotten a life insurance coverage through your employer or your individual particular person life policy. Is the benefit quantity enough to cowl your loved ones if your loved one is killed? But even you probably have life insurance coverage, what pays for the misery, the ache and struggling, possibly the fact you or a cherished one can’t walk or use their arms once more?
You may need a disability insurance coverage policy by means of your work if you happen to’re lucky or had good financial advice. However incapacity insurance doesn’t pay for lack of life, ache & struggling, everlasting lack of your legs, arm or hand.
The one protection that pays for these things is a part of an auto insurance coverage coverage known as Un/Underneath-insured motorist coverage. You’ll be able to only buy as a lot protection right here as you’ve in Legal responsibility coverage. Your auto insurance coverage agent ought to find a way that will help you decide the exact quantity you need.
3: Your Automotive
Comprehensive and Collision Protection are the third part of an auto insurance coverage policy and are sometimes referred to as “Full coverage.” Mainly the distinction is this: In the event you run into the tree you are lined by Collision coverage. If the tree runs into you (hypothetically of course), then you are covered by comprehensive coverage. Complete also covers damaged windshields, fire, theft and vandalism. The higher deductible (threat) you take here, the decrease the premium. Use the savings here to buy greater limits within the coverages that shield your assets and your family.
The underside line to determining proper auto insurance coverage protection is, after all, the money obtainable in your family budget. An excellent place to start out in determining the right auto insurance coverage coverage for your family is to meet with your native auto insurance coverage agent.
Most reduce-price corporations concern themselves with one factor only: Price. Tell them what protection you’ve gotten they usually’ll see if they’ll give you the same coverage for less. You turn into the insurance coverage professional. If this is the only want you’ve then that is ok. If not, you might want to seek the recommendation of an expert to help you determine the right quantity of coverage you want and how best to perform it.
Overview the following tips for auto insurance coverage protection to ensure you have enough to protect your family.

Go Here:

List of Banks

« Previous Page

1

…

56

57

58

59

60

…

68

Next Page »